evenfolio

Chemicals · NSE: LXCHEM

Laxmi Organic Industries

Q2 FY27 earnings highlights, from the results presentation

Price as of 16 Nov 2026
153.98−2.60%

Q2 FY27 · From the investor presentation

Read the filing on NSEFiling

30–116​acresLand parcel sizeSlides · p. 17
M.Cap
₹4,279Cr
P/E
24.9×
1Y return
−18.12%
From 52W high
−24.4%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue1,083700+54.7%968+11.8%
EBITDA10837+191.3%114-5.5%
EBITDA margin10.0%5.3%+468 bps11.8%-183 bps
PBTProfit before tax7516+381.0%92-18.8%
Net profit5711+417.3%68-15.8%
EPS (₹)2.040.40+410.0%2.44-16.4%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures. In Q2 FY27 the filing tags the owners' profit as ₹0 Cr against its own period profit; the period profit less minority interest is shown.

In short

  1. 01Q2 FY27 revenue was Rs 10,827 Mn, up 54.7% year on year.
  2. 02Q2 FY27 EBITDA was Rs 1,080 Mn; EBITDA margin 10.0% against 5.3% a year ago.
  3. 03Q2 FY27 PAT was Rs 570 Mn, up 417.6% year on year.
  4. 04Ethyl Acetate capacity at Lote stabilized; new Diketene capacity at Dahej commissioned.
  5. 05Dahej Phase II stabilisation and ramp-up, and Project Vaayu commissioning, are next.
  6. 06Specialties could not pass feedstock price rises to contract customers at once.
  7. 07Management expects continued volatility in the operating environment.

Capex

Dahej capex timeline lists Q3 stabilization and customer qualification

Slides · p. 10
“Q3 - Stabilization & Customer”

Dahej: consent-to-operate received

Slides · p. 10
“Consent-to-Operate received”

Next focus: stabilisation and ramp-up of Dahej Phase II

Slides · p. 11
“Stabilisation and Ramp-up of Dahej Phase II”

Next focus: commissioning of Project Vaayu

Slides · p. 11
“Commissioning of Project Vaayu”

Dahej capex timeline lists Q2 chemical charging

Slides · p. 10
“Q2 - Chemical Charging”

Capacity

Ethyl Acetate capacity at Lote stabilized; new Diketene capacity at Dahej commissioned

Slides · p. 4
“Ethyl Acetate capacity at Lote stabilized; new Diketene capacity at Dahej commissioned”

Essentials: Essentials growth driven by commissioning of ETAC capacity at Lote

Slides · p. 7
“Commissioning of ETAC Capacity at Lote”

Segments

Specialties: Specialties: Dahej ramp-up expected to bring operating leverage

Slides · p. 7
“Ramp up of Dahej will lead to operating leverage”

Specialties: Specialties delivered positive volumes and double-digit revenue and margin growth

Slides · p. 7
“Delivered positive volumes and strong double-digit revenue and reported margin”

Essentials: Essentials delivered double-digit volume, revenue and margin growth

Slides · p. 7
“Delivered strong double-digit volume, revenue and margin growths driven by –”

Demand

Double-digit volume and revenue growth across the portfolio in Q2 FY27

Slides · p. 4
“Strong double-digit volume and revenue growth across the portfolio”

More focus on customer engagement and long-term partnerships

Slides · p. 11
“Intensified focus on Customer engagement and Long-term partnerships”

Margins and costs

Q2 FY27 EBITDA margin 10.0% against 5.3% in Q2 FY26 and 11.8% in Q1 FY27

Slides · p. 8
“EBITDA Margin (%) 10.0% 5.3% 470 bps 11.8% -180 bps 10.8% 4.9% 600 bps”

Q2 FY27 gross margin 33.6%, against 33.1% a year ago and 37.5% in Q1 FY27

Slides · p. 8
“Gross Margins (%) 33.6% 33.1% 50 bps 37.5% -380 bps 35.4% 32.0% 340 bps”

Higher realizations, cost pass-through and operating leverage lifted margins despite higher energy and freight costs

Slides · p. 4
“Higher realizations, cost pass-through and operating leverage aided strong margin growth despite higher energy and freight costs”

Specialties: Specialties could not pass feedstock price increases to contract customers immediately

Slides · p. 7
“Feedstock price increased could not be immediately passed on to contract customers”

Essentials: Essentials: better price realizations from timely pass-through of cost inflation

Slides · p. 7
“Better price realizations due to timely pass through of cost inflation”

Debt and working capital

Q2 FY27 finance cost Rs 98 Mn, against Rs 57 Mn a year ago and Rs 43 Mn in Q1

Slides · p. 8
“Finance Cost 98 57 -0 43 -0 141 106 -0”

One-offs

Q2 FY26 and H1 FY26 EBITDA included one-time supply chain redesign expense of Rs 23 Mn and Rs 102 Mn

Slides · p. 6
“Q2FY26 and H1FY26 EBITDA includes one-time supply chain redesign project expense INR 23 Mn (PAT INR 17 Mn) and INR 102 Mn (PAT 76 Mn) respectively.”

Risks

Geopolitical disturbances made markets volatile, affecting feedstock prices and supply chain

Slides · p. 4
“Markets remained volatile due to geopolitical disturbances, impacting feedstock prices and supply chain”

Management expects continued volatility in the operating environment

Slides · p. 11
“Continued volatility across the broader operating environment”

Other

Q2 FY27 revenue from operations Rs 10,827 Mn, up 54.7% year on year

Slides · p. 8
“Revenue from operations 10,827 6,997 54.7% 9,683 11.8% 20,511 13,927 47.3%”

Q2 FY27 EBITDA Rs 1,080 Mn, up 191.3% year on year

Slides · p. 8
“EBITDA 1,080 371 191.3% 1,143 -5.5% 2,223 678 227.8%”

Q2 FY27 PAT Rs 570 Mn, up 417.6% year on year

Slides · p. 8
“PAT 570 110 417.6% 677 -15.8% 1,247 324 284.9%”

H1 FY27 revenue and EBITDA were the highest ever for a half year

Slides · p. 6
“Highest ever half-yearly Revenue and EBITDA”

Plan to expand green energy base

Slides · p. 11
“Expanding green energy base”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools